A cluster-randomised controlled trial, implementing CONn Syndrome screening and Evaluation in Primary care (CONSEP)

Not Applicable

Recruiting

Conditions: Hypertension
Cardiovascular - Hypertension
Metabolic and Endocrine - Other endocrine disorders

Registration Number: ACTRN12623001340628

Lead Sponsor: Department of Health and Aged Care

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 840

Inclusion Criteria

To be eligible, practices will:
(1) use Best PracticeTM Clinical Management Software;
(2) be accredited;
(3) provide general primary care services;
(4) plan to be in operation for the next 2 years;
(5) use Sonic Pathology (Melbourne Pathology in VIC, Clinpath Pathology in SA, Hobart Pathology in TAS) as default pathology;

Exclusion Criteria

To be eligible, practices need to be not:
(1)practices recruited for our prior educational intervention;
(2)practices which are previous users, current users or planning to use Guidance-based requests (GBR) to order pathology tests in the next 2 years;
(3) practices which share their database with other practices.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of eligible patients screened for primary aldosteronism[data extraction from Best Practice software 12 months after the commencement of intervention];Proportion of eligible patients diagnosed with primary aldosteronism[Data extraction from Best Practice software 24 months after the commencement of intervention]

Secondary Outcome Measures

Name	Time	Method
Rates of blood pressure control in eligible patients. [Data extraction from Best Practice software 12 and 24 months after the commencement of intervention];The amount (dose and frequency) of antihypertensive medication use in eligible patients. [Data extraction from Best Practice software 12 and 24 months after the commencement of intervention];Evaluate the barriers and enablers to the process of implementing the intervention to increase the screening and diagnosis of primary aldosteronism[30 minutes audio-recorded semi-structured interview conducted by members of the research team. 12 months after the commencement of intervention];the cost of the intervention[research notes (such as the printing cost and mailing cost of the recruitment materials) during the preparation and delivery of intervention]